The ERISA Industry Committee Calls on Congress to Close Loophole and Deem PBMs as a “Fiduciary” under ERISA
Independent Pharmacies of Maryland
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
Pharmacy Benefit Managers Are Killing Indie Pharmacies and Limiting Patient Choice
PBM executives decline to revise controversial testimony to House committee
It’s Not Just Big Pharma: Meet the Middlemen Blocking Access to Medication
PBM executives threatened with fines and jail time for alleged perjury in House hearing
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
States Keep Legal Pressure on PBMs Ahead of Potential FTC Suit
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
NCPA Leads Retail Pharmacy in a Class Action Suit Against Change Healthcare, UnitedHealth Group, and Optum for Data Breach and Losses
Do pharmacy benefit managers play a role in pharmacy closures?
Feds poised to sue pharmacy gatekeepers over high drug costs
Pharmacy benefit managers profit at expense of patients and small pharmacies, FTC says
Pa. legislators passed a law to regulate pharmacy middlemen. But the state doesn’t enforce it.
3Axis Report Scrutinizes PBM Spread Pricing Practice
Op-Ed: Health care middlemen don’t benefit NJ patients or pharmacists
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Independent pharmacists start ads asking Congress for relief from PBMs, ask Supreme Court to hear a case
Miyares joins cohort pressing for U.S. Supreme Court to review pharmacy benefit manager case
PHARMACIES: PBMs are killing independent owners